300601 康泰生物
交易中 11-05 14:42:42
资讯
新帖
简况
康泰生物(300601)披露2026年三季度报告,10月26日股价上涨1.6%
证券之星 · 10-26
康泰生物(300601)披露2026年三季度报告,10月26日股价上涨1.6%
300601,净利增长超93%!获公募基金加仓
东方财富网 · 10-26
300601,净利增长超93%!获公募基金加仓
康泰生物(300601)9月30日股东户数6.41万户,较上期增加5.38%
证券之星 · 10-26
康泰生物(300601)9月30日股东户数6.41万户,较上期增加5.38%
康泰生物最新公告:前三季度净利润同比增长93.97%
证券之星 · 10-26
康泰生物最新公告:前三季度净利润同比增长93.97%
股市必读:康泰生物新发布《2026年半年度权益分派实施公告》
证券之星 · 10-21
股市必读:康泰生物新发布《2026年半年度权益分派实施公告》
康泰生物(300601)披露可转债转股价格调整公告,10月20日股价下跌0.16%
证券之星 · 10-20
康泰生物(300601)披露可转债转股价格调整公告,10月20日股价下跌0.16%
康泰生物(300601)披露不向下修正“康泰转2”转股价格的公告,10月19日股价下跌0.24%
证券之星 · 10-19
康泰生物(300601)披露不向下修正“康泰转2”转股价格的公告,10月19日股价下跌0.24%
股市必读:康泰生物新发布《第八届董事会第十四次会议决议公告》
证券之星 · 10-19
股市必读:康泰生物新发布《第八届董事会第十四次会议决议公告》
股市必读:康泰生物新发布《关于吸附无细胞百白破(组分)联合疫苗(成人青少年及儿童用)开启Ⅰ期临床试验的公告》
证券之星 · 10-13
股市必读:康泰生物新发布《关于吸附无细胞百白破(组分)联合疫苗(成人青少年及儿童用)开启Ⅰ期临床试验的公告》
康泰生物(300601)9月30日主力资金净买入4258.26万元
证券之星 · 10-08
康泰生物(300601)9月30日主力资金净买入4258.26万元
康泰生物:以“内生创新+外延拓展”双轮驱动战略为指引
证券之星 · 09-30
康泰生物:以“内生创新+外延拓展”双轮驱动战略为指引
9月30日康泰生物涨6.18%,疫苗ETF嘉实基金重仓该股
证券之星 · 09-30
9月30日康泰生物涨6.18%,疫苗ETF嘉实基金重仓该股
股市必读:康泰生物(300601)9月29日董秘有最新回复
证券之星 · 09-30
股市必读:康泰生物(300601)9月29日董秘有最新回复
康泰生物:公司严格按照相关法律法规要求在定期报告中披露对应期末时点的股东人数
证券之星 · 09-29
康泰生物:公司严格按照相关法律法规要求在定期报告中披露对应期末时点的股东人数
康泰生物:以“内生创新+外延拓展”双轮驱动战略为指引
证券之星 · 09-29
康泰生物:以“内生创新+外延拓展”双轮驱动战略为指引
康泰生物:积极布局mRNA疫苗等前沿领域
证券之星 · 09-29
康泰生物:积极布局mRNA疫苗等前沿领域
康泰生物:公司财务结构稳健,持有现金约33.72亿元
证券之星 · 09-29
康泰生物:公司财务结构稳健,持有现金约33.72亿元
康泰生物:公司积极推动五联苗Ⅲ期临床试验进程
证券之星 · 09-29
康泰生物:公司积极推动五联苗Ⅲ期临床试验进程
9月21日康泰生物涨6.91%,疫苗ETF嘉实基金重仓该股
证券之星 · 09-21
9月21日康泰生物涨6.91%,疫苗ETF嘉实基金重仓该股
康泰生物涨6.91%,东海证券一周前给出“买入”评级
证券之星 · 09-21
康泰生物涨6.91%,东海证券一周前给出“买入”评级
加载更多
公司概况
公司名称:
深圳康泰生物制品股份有限公司
所属行业:
医药制造业
上市日期:
2017-02-07
主营业务:
深圳康泰生物制品股份有限公司的主营业务是人用疫苗的研发、生产和销售。公司的主要产品是免疫规划疫苗、非免疫规划疫苗。近年来,康泰生物荣获国家企业技术中心、国家技术发明奖二等奖、广东省预防医学会科技进步奖特等奖、深圳市科技进步奖一等奖、中国生物医药企业20强等多项殊荣,在传染病预防领域创造的社会价值及经济效益得到社会各界普遍认可。
发行价格:
3.29
{"stockData":{"symbol":"300601","market":"SZ","secType":"STK","nameCN":"康泰生物","latestPrice":12.88,"timestamp":1793860962000,"preClose":12.7,"halted":0,"volume":16107368,"delay":0,"changeRate":0.0142,"floatShares":900000000,"shares":1117000000,"eps":0.1044,"marketStatus":"交易中","change":0.18,"latestTime":"11-05 14:42:42","open":12.73,"high":13.03,"low":12.73,"amount":208000000,"amplitude":0.0236,"askPrice":12.88,"askSize":1821,"bidPrice":12.87,"bidSize":520,"shortable":0,"etf":0,"ttmEps":0.1044,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1793862000000},"marketStatusCode":2,"adr":0,"adjPreClose":12.7,"symbolType":"stock","openAndCloseTimeList":[[1793842200000,1793849400000],[1793854800000,1793862000000]],"highLimit":13.97,"lowLimit":11.43,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1116931860,"isCdr":false,"pbRate":1.55,"roa":"--","peRate":123.371648,"roe":"0.99%","epsLYR":0.06,"committee":-0.008614,"marketValue":14386000000,"turnoverRate":0.0179,"status":0,"floatMarketCap":11597000000},"requestUrl":"/m/hq/s/300601","defaultTab":"news","newsList":[{"id":"2678419465","title":"康泰生物(300601)披露2026年三季度报告,10月26日股价上涨1.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678419465","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678419465?lang=zh_cn&edition=full","pubTime":"2026-10-26 22:39","pubTimestamp":1793025554,"startTime":"0","endTime":"0","summary":"截至2026年10月26日收盘,康泰生物报收于12.69元,较前一交易日上涨1.6%,最新总市值为141.74亿元。该股当日开盘12.35元,最高12.79元,最低12.35元,成交额达1.56亿元,换手率为1.38%。近日,康泰生物披露2026年三季度报告。报告显示,本报告期营业收入567,831,798.41元,同比下降15.42%;归属于上市公司股东的净利润44,965,062.38元,同比增长286.80%。年初至报告期末营业收入1,840,837,989.25元,同比下降10.79%;归属于上市公司股东的净利润95,351,149.23元,同比增长93.97%。经营活动产生的现金流量净额251,718,582.61元,同比下降30.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600037968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","BK0046","300601"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678195409","title":"300601,净利增长超93%!获公募基金加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2678195409","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678195409?lang=zh_cn&edition=full","pubTime":"2026-10-26 20:29","pubTimestamp":1793017740,"startTime":"0","endTime":"0","summary":"康泰生物前三季度净利增长93.97%。10月26日晚,康泰生物(300601)发布2026年第三季度报告。2026年前三季度,公司实现营业收入18.41亿元,同比下降10.79%,其中海外业务实现收入1.02亿元,同比增长143.88%;归母净利润9535.11万元,同比增长93.97%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://finance.eastmoney.com/news/1354,202610263908458648.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202610263908458648.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["BK0201","BK0046","BK0239","300601"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678063169","title":"康泰生物(300601)9月30日股东户数6.41万户,较上期增加5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678063169","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678063169?lang=zh_cn&edition=full","pubTime":"2026-10-26 17:58","pubTimestamp":1793008713,"startTime":"0","endTime":"0","summary":"证券之星消息,近日康泰生物披露,截至2026年9月30日公司股东户数为6.41万户,较6月30日增加3273.0户,增幅为5.38%。在生物制品行业个股中,康泰生物股东户数高于行业平均水平,截至9月30日,生物制品行业平均股东户数为3.62万户。从股价来看,2026年6月30日至2026年9月30日,康泰生物区间涨幅为19.75%,在此期间股东户数增加3273.0户,增幅为5.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600024394.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0201","300601","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678166980","title":"康泰生物最新公告:前三季度净利润同比增长93.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678166980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678166980?lang=zh_cn&edition=full","pubTime":"2026-10-26 17:25","pubTimestamp":1793006735,"startTime":"0","endTime":"0","summary":"康泰生物(300601.SZ)公告称,第三季度营业收入为5.68亿元,同比下降15.42%;归属于上市公司股东的净利润为4496.51万元,同比增长286.80%。前三季度营业收入为18.41亿元,同比下降10.79%;归属于上市公司股东的净利润为9535.11万元,同比增长93.97%。注:公司Q3净利润0.45亿,Q2净利润0.17亿,据此计算,Q3净利润环比增长163%。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600023232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300601"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677618051","title":"股市必读:康泰生物新发布《2026年半年度权益分派实施公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677618051","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677618051?lang=zh_cn&edition=full","pubTime":"2026-10-21 01:54","pubTimestamp":1792518853,"startTime":"0","endTime":"0","summary":"截至2026年10月20日收盘,康泰生物报收于12.38元,下跌0.16%,换手率1.14%,成交量10.23万手,成交额1.26亿元。股权登记日为2026年10月27日,除权除息日为2026年10月28日。现金红利由中国证券登记结算有限责任公司深圳分公司代派,部分股东由公司自行派发。关于可转债转股价格调整的公告深圳康泰生物制品股份有限公司因实施2026年半年度权益分派,向全体股东每10股派0.27元(含税)现金红利,根据可转换公司债券相关规定,对“康泰转2”转股价格进行调整。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100001635.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300601","BK0046","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676694989","title":"康泰生物(300601)披露可转债转股价格调整公告,10月20日股价下跌0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676694989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676694989?lang=zh_cn&edition=full","pubTime":"2026-10-20 22:24","pubTimestamp":1792506265,"startTime":"0","endTime":"0","summary":"截至2026年10月20日收盘,康泰生物报收于12.38元,较前一交易日下跌0.16%,最新总市值为138.28亿元。该股当日开盘12.37元,最高12.48元,最低12.2元,成交额达1.26亿元,换手率为1.14%。公告显示,因实施2026年半年度权益分派,向全体股东每10股派0.27元(含税)现金红利,根据可转换公司债券相关规定,对“康泰转2”转股价格进行调整。调整前转股价格为15.69元/股,调整后为15.66元/股,调整后的转股价格自2026年10月28日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000036925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","300601","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676977504","title":"康泰生物(300601)披露不向下修正“康泰转2”转股价格的公告,10月19日股价下跌0.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676977504","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676977504?lang=zh_cn&edition=full","pubTime":"2026-10-19 17:30","pubTimestamp":1792402236,"startTime":"0","endTime":"0","summary":"截至2026年10月19日收盘,康泰生物报收于12.4元,较前一交易日下跌0.24%,最新总市值为138.5亿元。公告显示,自2026年9月16日至2026年10月16日,公司股票在连续三十个交易日中有十五个交易日的收盘价低于当期转股价格的85%,触发“康泰转2”转股价格向下修正条款。公司于2026年10月16日召开第八届董事会第十四次会议,审议通过不向下修正“康泰转2”转股价格的议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900022462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0201","300601"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676573611","title":"股市必读:康泰生物新发布《第八届董事会第十四次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2676573611","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676573611?lang=zh_cn&edition=full","pubTime":"2026-10-19 03:10","pubTimestamp":1792350621,"startTime":"0","endTime":"0","summary":"董事、总裁苗向因持有“康泰转2”可转债回避表决。关于公司银行账户部分资金被冻结的公告深圳康泰生物制品股份有限公司于2026年10月15日发现公司银行基本账户部分资金被冻结,冻结金额为4,305.77万元。公司尚未收到法院正式法律文书,案件尚未开庭。公司于2026年10月16日召开第八届董事会第十四次会议,审议通过不向下修正“康泰转2”转股价格的议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900000967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","300601","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675804115","title":"股市必读:康泰生物新发布《关于吸附无细胞百白破(组分)联合疫苗(成人青少年及儿童用)开启Ⅰ期临床试验的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675804115","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675804115?lang=zh_cn&edition=full","pubTime":"2026-10-13 01:55","pubTimestamp":1791827715,"startTime":"0","endTime":"0","summary":"截至2026年10月12日收盘,康泰生物报收于13.17元,下跌2.01%,换手率2.54%,成交量22.88万手,成交额3.06亿元。公司公告汇总:康泰生物全资子公司民海生物研发的吸附无细胞百白破(组分)联合疫苗已启动Ⅰ期临床试验并完成首例受试者入组,该疫苗适用于6岁及以上人群,目前国内尚无同类产品获批上市。该疫苗适用于6岁及以上人群,用于预防百日咳、白喉、破伤风。Ⅰ期临床试验采用随机、盲法、对照设计,评估其安全性和免疫原性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300001878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300601","BK0046","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673281049","title":"康泰生物(300601)9月30日主力资金净买入4258.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673281049","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673281049?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:02","pubTimestamp":1791421365,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月30日收盘,康泰生物报收于13.58元,上涨6.18%,换手率3.89%,成交量35.01万手,成交额4.7亿元。近5日资金流向一览见下表:康泰生物融资融券信息显示,融资方面,当日融资买入2838.73万元,融资偿还4295.67万元,融资净偿还1456.94万元。康泰生物主营业务:人用疫苗的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800002867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300601","BK0046","BK0239","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671023072","title":"康泰生物:以“内生创新+外延拓展”双轮驱动战略为指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2671023072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671023072?lang=zh_cn&edition=full","pubTime":"2026-09-30 20:51","pubTimestamp":1790772665,"startTime":"0","endTime":"0","summary":"证券之星消息,康泰生物09月29日在投资者关系平台上答复投资者关心的问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000036025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0201","300601","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671227286","title":"9月30日康泰生物涨6.18%,疫苗ETF嘉实基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2671227286","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671227286?lang=zh_cn&edition=full","pubTime":"2026-09-30 16:39","pubTimestamp":1790757576,"startTime":"0","endTime":"0","summary":"证券之星消息,9月30日康泰生物涨6.18%,收盘报13.58元,换手率3.89%,成交量35.01万手,成交额4.7亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为嘉实基金的疫苗ETF嘉实。疫苗ETF嘉实目前规模为2.13亿元,最新净值0.6586,较上一交易日上涨0.11%,近一年上涨13.79%。疫苗ETF嘉实的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000026091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["562860","BK0201","300601","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671524100","title":"股市必读:康泰生物(300601)9月29日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2671524100","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671524100?lang=zh_cn&edition=full","pubTime":"2026-09-30 02:30","pubTimestamp":1790706632,"startTime":"0","endTime":"0","summary":"截至2026年9月29日收盘,康泰生物报收于12.79元,下跌0.54%,换手率1.24%,成交量11.2万手,成交额1.44亿元。董秘最新回复投资者: 五联苗三期入组后,效果如何了?股东若需查询其他时点股东人数,可持本人持股证明、身份证件前往公司证券部现场查阅。当日关注点交易信息汇总:9月29日主力资金净流入160.23万元,占总成交额1.12%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000002601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0201","300601"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671297433","title":"康泰生物:公司严格按照相关法律法规要求在定期报告中披露对应期末时点的股东人数","url":"https://stock-news.laohu8.com/highlight/detail?id=2671297433","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671297433?lang=zh_cn&edition=full","pubTime":"2026-09-29 17:03","pubTimestamp":1790672590,"startTime":"0","endTime":"0","summary":"证券之星消息,康泰生物09月29日在投资者关系平台上答复投资者关心的问题。股东若需查询其他时点股东人数,可持本人持股证明、身份证件前往公司证券部现场查阅。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900027763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","BK0046","300601"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671484297","title":"康泰生物:以“内生创新+外延拓展”双轮驱动战略为指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2671484297","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671484297?lang=zh_cn&edition=full","pubTime":"2026-09-29 17:00","pubTimestamp":1790672444,"startTime":"0","endTime":"0","summary":"证券之星消息,康泰生物09月29日在投资者关系平台上答复投资者关心的问题。公司将继续做好与投资者及市场的沟通工作,传递公司投资价值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900027720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","300601","BK0239","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671295292","title":"康泰生物:积极布局mRNA疫苗等前沿领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2671295292","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671295292?lang=zh_cn&edition=full","pubTime":"2026-09-29 16:36","pubTimestamp":1790670976,"startTime":"0","endTime":"0","summary":"公司目前建立了病毒疫苗、细菌疫苗、基因工程蛋白疫苗、多糖蛋白结合疫苗、联合疫苗、病毒载体疫苗、新型佐剂、mRNA 核酸疫苗等多元化研发平台。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900027140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0201","300601"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671294997","title":"康泰生物:公司财务结构稳健,持有现金约33.72亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671294997","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671294997?lang=zh_cn&edition=full","pubTime":"2026-09-29 16:03","pubTimestamp":1790668998,"startTime":"0","endTime":"0","summary":"证券之星消息,康泰生物09月29日在投资者关系平台上答复投资者关心的问题。康泰生物回复:您好,一方面,在转股期内如果公司股票在任意连续三十个交易日中至少十五个交易日的收盘价格不低于当期转股价格的130%,公司可以提前赎回可转债。另一方面,公司财务结构稳健,2026年上半年末公司持有现金约33.72亿元,资产负债率维持在30.64%的较低水平,具备充足资金用于本次可转债兑付。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900023905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0201","300601"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671949872","title":"康泰生物:公司积极推动五联苗Ⅲ期临床试验进程","url":"https://stock-news.laohu8.com/highlight/detail?id=2671949872","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671949872?lang=zh_cn&edition=full","pubTime":"2026-09-29 16:00","pubTimestamp":1790668850,"startTime":"0","endTime":"0","summary":"证券之星消息,康泰生物(300601)09月29日在投资者关系平台上答复投资者关心的问题。投资者提问:五联苗三期入组后,效果如何了?能不能成功?康泰生物回复:您好,公司积极推动五联苗Ⅲ期临床试验进程,目前已完成受试者入组,后续相关产品研发及注册进展达到信息披露标准,公司将会根据相关法律法规的规定履行信息披露义务。感谢您对公司的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900023631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","300601","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669159289","title":"9月21日康泰生物涨6.91%,疫苗ETF嘉实基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669159289","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669159289?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:46","pubTimestamp":1789980404,"startTime":"0","endTime":"0","summary":"证券之星消息,9月21日康泰生物涨6.91%,收盘报12.99元,换手率4.49%,成交量40.44万手,成交额5.17亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为嘉实基金的疫苗ETF嘉实。疫苗ETF嘉实目前规模为2.13亿元,最新净值0.6374,较上一交易日上涨2.11%,近一年上涨13.79%。疫苗ETF嘉实的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100021028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["562860","BK0239","300601","BK0201","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669159211","title":"康泰生物涨6.91%,东海证券一周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2669159211","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669159211?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:46","pubTimestamp":1789980390,"startTime":"0","endTime":"0","summary":"今日康泰生物涨6.91%,收盘报12.99元。2026年9月11日,东海证券研究员杜永宏发布了对康泰生物的研报《公司简评报告:积极拓展国内外市场,研发顺利推进》,该研报对康泰生物给出“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为国投证券的冯俊曦、李奔。康泰生物个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100021019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300601","161027"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793860965135,"stockEarnings":[{"period":"1week","weight":0.0136},{"period":"1month","weight":-0.0627},{"period":"3month","weight":0.0407},{"period":"6month","weight":-0.1214},{"period":"1year","weight":-0.2534},{"period":"ytd","weight":-0.1356}],"compareEarnings":[{"period":"1week","weight":0.0013},{"period":"1month","weight":-0.0406},{"period":"3month","weight":-0.0549},{"period":"6month","weight":-0.1181},{"period":"1year","weight":-0.0692},{"period":"ytd","weight":-0.0712}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳康泰生物制品股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"64149人(较上一季度增加5.38%)","perCapita":"14035股","listingDate":"2017-02-07","address":"广东省深圳市南山区粤海街道科技园社区科发路222号康泰集团大厦","registeredCapital":"111693万元","survey":" 深圳康泰生物制品股份有限公司的主营业务是人用疫苗的研发、生产和销售。公司的主要产品是免疫规划疫苗、非免疫规划疫苗。近年来,康泰生物荣获国家企业技术中心、国家技术发明奖二等奖、广东省预防医学会科技进步奖特等奖、深圳市科技进步奖一等奖、中国生物医药企业20强等多项殊荣,在传染病预防领域创造的社会价值及经济效益得到社会各界普遍认可。","listedPrice":3.29},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康泰生物(300601)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康泰生物(300601)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康泰生物,300601,康泰生物股票,康泰生物股票老虎,康泰生物股票老虎国际,康泰生物行情,康泰生物股票行情,康泰生物股价,康泰生物股市,康泰生物股票价格,康泰生物股票交易,康泰生物股票购买,康泰生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康泰生物(300601)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康泰生物(300601)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}